Correction: Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a Novel Dual mGluR5/5‑HT2AR Antagonist (VVZ‑2471) in a Randomized, Double‑Blind, First‑in‑Human Study

CNS Drugs 2026 Open access

Read full text

Authors: Sungyeun Bae, HyunJoon Lee, Inkyung Song, Jina Kim, Sang Rim Lee, Sunyoung Cho, Kyung‑Sang Yu, Jae-Yong Chung

DOI: 10.1007/s40263-026-01279-8

Cited by: 0

Fields of Study & Subjects

Neuroscience and Neuropharmacology Research Schizophrenia research and treatment Treatment of Major Depression